GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kubota Pharmaceutical Holdings Co Ltd (TSE:4596) » Definitions » EV-to-FCF

Kubota Pharmaceutical Holdings Co (TSE:4596) EV-to-FCF : -1.06 (As of May. 21, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Kubota Pharmaceutical Holdings Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Kubota Pharmaceutical Holdings Co's Enterprise Value is 円1,482.47 Mil. Kubota Pharmaceutical Holdings Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was 円-1,402.23 Mil. Therefore, Kubota Pharmaceutical Holdings Co's EV-to-FCF for today is -1.06.

The historical rank and industry rank for Kubota Pharmaceutical Holdings Co's EV-to-FCF or its related term are showing as below:

TSE:4596' s EV-to-FCF Range Over the Past 10 Years
Min: -8.15   Med: -1.23   Max: 2.1
Current: -0.98

During the past 9 years, the highest EV-to-FCF of Kubota Pharmaceutical Holdings Co was 2.10. The lowest was -8.15. And the median was -1.23.

TSE:4596's EV-to-FCF is ranked worse than
100% of 379 companies
in the Biotechnology industry
Industry Median: 8.34 vs TSE:4596: -0.98

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-21), Kubota Pharmaceutical Holdings Co's stock price is 円71.00. Kubota Pharmaceutical Holdings Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円-26.820. Therefore, Kubota Pharmaceutical Holdings Co's PE Ratio for today is At Loss.


Kubota Pharmaceutical Holdings Co EV-to-FCF Historical Data

The historical data trend for Kubota Pharmaceutical Holdings Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kubota Pharmaceutical Holdings Co EV-to-FCF Chart

Kubota Pharmaceutical Holdings Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only -1.45 -2.35 -1.17 -1.20 -1.41

Kubota Pharmaceutical Holdings Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.20 -1.41 -1.52 -1.34 -1.41

Competitive Comparison of Kubota Pharmaceutical Holdings Co's EV-to-FCF

For the Biotechnology subindustry, Kubota Pharmaceutical Holdings Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kubota Pharmaceutical Holdings Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kubota Pharmaceutical Holdings Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Kubota Pharmaceutical Holdings Co's EV-to-FCF falls into.



Kubota Pharmaceutical Holdings Co EV-to-FCF Calculation

Kubota Pharmaceutical Holdings Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1482.465/-1402.226
=-1.06

Kubota Pharmaceutical Holdings Co's current Enterprise Value is 円1,482.47 Mil.
Kubota Pharmaceutical Holdings Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-1,402.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kubota Pharmaceutical Holdings Co  (TSE:4596) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Kubota Pharmaceutical Holdings Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=71.00/-26.820
=At Loss

Kubota Pharmaceutical Holdings Co's share price for today is 円71.00.
Kubota Pharmaceutical Holdings Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-26.820.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Kubota Pharmaceutical Holdings Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Kubota Pharmaceutical Holdings Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Kubota Pharmaceutical Holdings Co (TSE:4596) Business Description

Traded in Other Exchanges
N/A
Address
3-7-1 Kasumigaseki, 4th Floor,Kasumigaseki Tokyu Building, Chiyoda-ku, Tokyo, JPN, 150-6018
Kubota Pharmaceutical Holdings Co Ltd is a Japanese company providing portfolio of drugs and devices to preserve and restore millions of people. It identifies and develops therapeutics to treat the opthalmic disorder and operations incidental or related thereto. Its pipeline products include VCM-Emixustat HCI, Lanosterol and Optogenetics.

Kubota Pharmaceutical Holdings Co (TSE:4596) Headlines

No Headlines